Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.

[1]  James H Beaty,et al.  Changes in the Treatment of Pediatric Femoral Fractures: 15-Year Trends From United States Kids’ Inpatient Database (KID) 1997 to 2012 , 2016, Journal of pediatric orthopedics.

[2]  K. Vassiou,et al.  Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine , 2016, Infectious diseases.

[3]  U. Demkow,et al.  Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests. , 2016, Respiratory Medicine.

[4]  Peter D. Fabricant,et al.  Medial Epicondyle Fractures in Children and Adolescents: Shifting Care from General Hospitals to Children's Hospitals? , 2015, The Journal of pediatrics.

[5]  S. McKay,et al.  National Trends in Operative Treatment of Pediatric Fractures in the Ambulatory Setting. , 2015, Orthopedics.

[6]  S. Saxena,et al.  Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England. , 2015, The Journal of infection.

[7]  James A Singleton,et al.  National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19-35 Months - United States, 2014. , 2015, MMWR. Morbidity and mortality weekly report.

[8]  K. Konty,et al.  Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012. , 2015, JAMA pediatrics.

[9]  S. Kaplan,et al.  Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  N. Dean,et al.  Pneumonia and empyema: causal, casual or unknown. , 2015, Journal of thoracic disease.

[11]  Dennis R Durbin,et al.  Long-term changes in crash rates after introduction of a Graduated Driver Licensing decal provision. , 2015, American journal of preventive medicine.

[12]  C. Whitney,et al.  Declines in Pneumonia Hospitalizations of Children Aged <2 Years Associated with the Use of Pneumococcal Conjugate Vaccines — Tennessee, 1998–2012 , 2014, MMWR. Morbidity and mortality weekly report.

[13]  S. Turner,et al.  Has the incidence of empyema in Scottish children continued to increase beyond 2005? , 2014, Archives of Disease in Childhood.

[14]  K. Monroe,et al.  Trends in Alabama teen driving death and injury , 2014, The journal of trauma and acute care surgery.

[15]  M. Kolasa,et al.  National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2013 , 2014, MMWR. Morbidity and mortality weekly report.

[16]  J. Meis,et al.  Effects of 7-valent pneumococcal conjugate 1 vaccine on the severity of adult 2 bacteremic pneumococcal pneumonia. , 2014, Vaccine.

[17]  D. Greenberg,et al.  Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance. , 2014, Vaccine.

[18]  Á. Gentile.  [U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination]. , 2014, Archivos argentinos de pediatria.

[19]  S. Pelton,et al.  Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Grabenstein,et al.  Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. , 2014, Vaccine.

[21]  Robert J. Taylor,et al.  Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis. , 2014, The Lancet. Respiratory medicine.

[22]  H. Schmitt,et al.  Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[23]  Samir S. Shah,et al.  Identifying pediatric community-acquired pneumonia hospitalizations: Accuracy of administrative billing codes. , 2013, JAMA pediatrics.

[24]  J. Casado‐flores,et al.  Impact of Introduction of Conjugate Vaccines in the Vaccination Schedule on the Incidence of Pediatric Invasive Pneumococcal Disease Requiring Hospitalization in Madrid 2007 to 2011 , 2013, The Pediatric infectious disease journal.

[25]  S. Rushton,et al.  Emergence of pneumococcal 19A empyema in UK children , 2012, Archives of Disease in Childhood.

[26]  Vital signs: Unintentional injury deaths among persons aged 0-19 years - United States, 2000-2009. , 2012, MMWR. Morbidity and mortality weekly report.

[27]  C. Byington,et al.  Evolution of the Epidemiology of Pneumococcal Disease Among Utah Children Through the Vaccine Era , 2011, The Pediatric infectious disease journal.

[28]  H. Selvadurai,et al.  Bacterial Causes of Empyema in Children, Australia, 2007–2009 , 2011, Emerging infectious diseases.

[29]  C. Toscano,et al.  Pneumococcal disease manifestation in children before and after vaccination: what's new? , 2011, Vaccine.

[30]  A. Harnden,et al.  British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011 , 2011, Thorax.

[31]  Yuwei Zhu,et al.  Emergence of parapneumonic empyema in the USA , 2011, Thorax.

[32]  James E. Levin,et al.  Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood. , 2011, Journal of hospital medicine.

[33]  C. Byington,et al.  Molecular Analysis Improves Pathogen Identification and Epidemiologic Study of Pediatric Parapneumonic Empyema , 2011, The Pediatric infectious disease journal.

[34]  C. Whitney,et al.  Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[35]  G. Waterer,et al.  Empyema thoracis: new insights into an old disease , 2010, European Respiratory Review.

[36]  S. Saxena,et al.  Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997–2008 , 2010, Thorax.

[37]  C. Muñoz-Almagro,et al.  Influence of pneumococcal vaccine on the incidence of empyema , 2010, Current opinion in pulmonary medicine.

[38]  Yuwei Zhu,et al.  Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  C. Byington,et al.  Molecular Epidemiology of Pediatric Pneumococcal Empyema from 2001 to 2007 in Utah , 2009, Journal of Clinical Microbiology.

[40]  S. Sahn.  Diagnosis and management of parapneumonic effusions and empyema. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  Madison,et al.  National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2011. , 2012, MMWR. Morbidity and mortality weekly report.

[42]  A. Elixhauser,et al.  Overview of Hospital Stays for Children in the United States, 2012 , 2006 .

[43]  T. File,et al.  Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. , 1999, American journal of epidemiology.